- Home
- BESS vs DYAI Comparison
BESS vs DYAI Comparison
Compare BESS & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BESS | DYAI |
|---|---|---|
| Founded | 1998 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 17.0M |
| IPO Year | 2022 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BESS | DYAI |
|---|---|---|
| Price | $2.91 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 268.8K | 91.2K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $168,880.00 | ★ $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | $206.88 | $94.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.52 | $0.33 |
| 52 Week High | $6.45 | $1.60 |
Technical Indicators
Market Signals| Indicator | BESS | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 36.72 |
| Support Level | $2.75 | N/A |
| Resistance Level | $3.17 | $0.48 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 42.81 | 8.59 |
Price Performance
Historical ComparisonAbout BESS Bimergen Energy Corporation Common Stock
Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.